US-based diabetes software app, Glooko has announced a partnership with the Association of British Clinical Diabetologists (ABCD) / Diabetes Technology Network (DTN), to launch an online medical education programme for clinicians who treat people with diabetes in the UK.

A leading diabetes software company is taking action to serve the global diabetes community amid the current COVID-19 pandemic and offering a free, remote care solution for healthcare professionals.

As America and the rest of the world grapples with the escalating global coronavirus pandemic of 2020, healthcare providers are transitioning to remote patient care — often on the fly. While hospitals are adopting emergency action plans.

Digital diabetes management company Glooko has announced the appointments of a new CCO and COO. The first role went to Zach Henderson, formerly of LexisNexis Health Care and Elsevier.

Glooko, a provider of diabetes data management solutions, announced the appointment of Mark Clements, MD, Ph.D., CPI, FAAP, as Chief Medical Officer. Dr. Clements joins the senior management team of Glooko having served on its medical advisory.

Glooko’s diabetes management platform will be used to incorporate data from devices like insulin pumps, CGMs and glucometers into the T1D Exchange Quality Improvement Collaborative as part of a new partnership.